Sarepta FDA Investigation - Search News

Order byBest matchMost fresh

News

FDA asks Sarepta to stop shipping gene therapy

· 4d · on MSN

FDA Is Investigating If Sarepta’s Gene Therapy Should Stay on Market

US Food and Drug Administration Commissioner Marty Makary said he’s “taking a hard look” at whether a gene therapy from Sarepta Therapeutics Inc. should remain on the market.Makary made the comments in an interview with Bloomberg News.

Continue reading

· 9h · on MSN

Sarepta shares slide again as drugmaker bows to FDA pressure to pause gene therapy

BioPharma Dive · 1d

FDA asks Sarepta to stop shipping Duchenne gene therapy

1don MSN

FDA Suspends Muscular Dystrophy Drug After 3 Patient Deaths

The U.S. Food and Drug Administration ( FDA) has placed an immediate clinical hold on Sarepta Therapeutics' investigational ...

Pharmalittle: We’re reading about Sarepta conceding to the FDA, the U.S. transplant system, and more

Sarepta Therapeutics reversed course and agreed to halt all shipments of Elevidys, its gene therapy for Duchenne muscular ...

NBC4 WCMH-TV on MSN3d

Sarepta Therapeutics lays off 500 employees amid FDA investigation, including 80 in Columbus

Sarepta Therapeutics announced it is laying off nearly 500 employees this week, including 80 at its Easton location.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results